[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.180.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1964

Anterior Chest Wall—Superficial ThrombophlebitisMondor's Disease

Author Affiliations

SALT LAKE CITY
Dean (Dr. Castleton); Research Fellow, Division of Arthritis (Dr. Cloud); Associate Professor of Medicine and Chief, Division of Arthritis, Department of Internal Medicine (Dr. Ward); University of Utah College of Medicine.; From the departments of surgery and medicine, University of Utah College of Medicine, and the Salt Lake County General Hospital.

Arch Surg. 1964;88(6):1010-1012. doi:10.1001/archsurg.1964.01310240106019
Abstract

In 1939 Mondor1 described the clinical and pathological features of a benign, selflimited phlebitis and periphlebitis of superficial veins on the anterior chest wall. He originally used the term "angeitis" and later identified the pathology as a thrombophlebitis,2 confirming the clinical impression of Shields,3 Fiessinger and Mathieu,4 and Daniels.5 Since Mondor's original paper the eponym, Mondor's disease, has been used commonly.

Although there are fewer than 200 cases reported, Mondor's disease is probably of common clinical occurrence. Farrow6 reported 43 patients, of whom 18 were seen in one year, and Adair7 saw 26 patients with the disease in eight years. The clinical features are clearly diagnostic. The occurrence of pain and the presence of a tender, subcutaneous linear cord in the distribution of the superficial veins of the anterolateral chest wall or upper abdomen make the diagnosis. The presence of cellulitis, abscesses, or

First Page Preview View Large
First page PDF preview
First page PDF preview
×